795 related articles for article (PubMed ID: 5538813)
41. Studies in clinical shock and hypotension. VII. Renal hemodynamics before and during treatment.
Tristani FE; Cohn JN
Circulation; 1970 Nov; 42(5):839-51. PubMed ID: 4320083
[No Abstract] [Full Text] [Related]
42. Isoproterenol and norepinephrine therapy for pulmonary embolism shock.
Rosenberg JC; Hussain R; Lenaghan R
J Thorac Cardiovasc Surg; 1971 Jul; 62(1):144-50. PubMed ID: 5091678
[No Abstract] [Full Text] [Related]
43. Clinical appraisal of shock following acute myocardial infarction.
Mir MA; Rees S; Yahya AM; Williams JD; Reeves TL
Cardiology; 1974; 59(2):69-82. PubMed ID: 4434361
[No Abstract] [Full Text] [Related]
44. [Vaspressors or vasodilators in traumatic and hypovolemic shock].
Ahnefeld FW; Halmágyi M
Klin Med Osterr Z Wiss Prakt Med; 1967; 22(7):325-9. PubMed ID: 5632398
[No Abstract] [Full Text] [Related]
45. Current therapy of shock.
Goldberg LI; Talley RC
Adv Intern Med; 1971; 17():363-78. PubMed ID: 4147306
[No Abstract] [Full Text] [Related]
46. Vasopressors and low-flow states.
Hershey SG; Altura BM
Clin Anesth; 1974; 10(1):31-76. PubMed ID: 4149702
[No Abstract] [Full Text] [Related]
47. Vasoactive drug support in septic shock.
Dries DJ
Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
[No Abstract] [Full Text] [Related]
48. Hypovolemic shock: microcirculatory changes during and after specific therapy.
Stallworth JM; Ramirez A; Barrington BA; Bradham RR
Ann Surg; 1969 May; 169(5):694-703. PubMed ID: 4305267
[No Abstract] [Full Text] [Related]
49. [Indications, in anesthesia-resuscitation, for various analeptics during obstetrical shock].
Mai van Dau C
Anesth Analg (Paris); 1969; 26(5):743-8. PubMed ID: 4312808
[No Abstract] [Full Text] [Related]
50. Current status of the treatment of shock complicating acute myocardial infarction.
Friedberg CK
J Trauma; 1969 Feb; 9(2):141-2. PubMed ID: 5763330
[No Abstract] [Full Text] [Related]
51. Protective effects of nylidrin and isoproterenol against hemorrhagic shock.
Grega GJ; Kinnard WJ
J Pharmacol Exp Ther; 1968 May; 161(1):98-110. PubMed ID: 5648505
[No Abstract] [Full Text] [Related]
52. Use of corticosteroids in the treatment of shock.
Motsay GJ; Romero LH; Lillehei RC
Int Surg; 1974; 59(11-12):593-600. PubMed ID: 4443176
[No Abstract] [Full Text] [Related]
53. Vasopressors for treating shock.
Moyer JH; Mills LC
Postgrad Med; 1974 Aug; 56(2):172-80. PubMed ID: 4855378
[TBL] [Abstract][Full Text] [Related]
54. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
[TBL] [Abstract][Full Text] [Related]
55. The problem of acute severe trauma and shock.
Hardaway RM
Surg Gynecol Obstet; 1971 Nov; 133(5):799-806. PubMed ID: 5111116
[No Abstract] [Full Text] [Related]
56. The pharmacologic approach to the treatment of shock. I. Defining traumatic, septic, and cardiogenic shock.
Lillehei RC; Dietzman RH; Motsay GJ; Schultz LS; Romero LH; Beckman CB
Geriatrics; 1972 Jul; 27(7):73-83. PubMed ID: 5039885
[No Abstract] [Full Text] [Related]
57. [Shock and its treatment wuth chemotherapeutic agents].
Fujita M; Iwabuchi K
Jibiinkoka; 1969 Oct; 40(10):843-50. PubMed ID: 5812656
[No Abstract] [Full Text] [Related]
58. [Use of isoproterenol in the treatment of shock].
Péntek L
Bruns Beitr Klin Chir (1971); 1969 Jun; 217(4):355-62. PubMed ID: 5372149
[No Abstract] [Full Text] [Related]
59. Effect of dopamine and metaraminol on the renal function of patients with septic shock.
Hou LC; Li SZ; Xiong LZ; Chen SY; Chen M; Zhang XJ; Huo TT; Wang Q; Wang YL; Hu WN
Chin Med J (Engl); 2007 Apr; 120(8):680-3. PubMed ID: 17517184
[TBL] [Abstract][Full Text] [Related]
60. Pressor agents in cardiogenic shock.
Corday E; Lillehei RC
Am J Cardiol; 1969 Jun; 23(6):900-10. PubMed ID: 5785170
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
